HK1214622A1 - 含用於純化芳基硫酸酯酶 的方法 - Google Patents
含用於純化芳基硫酸酯酶 的方法Info
- Publication number
- HK1214622A1 HK1214622A1 HK16102496.7A HK16102496A HK1214622A1 HK 1214622 A1 HK1214622 A1 HK 1214622A1 HK 16102496 A HK16102496 A HK 16102496A HK 1214622 A1 HK1214622 A1 HK 1214622A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- rylsulfatase
- purification
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/12—Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/06—Sulfuric ester hydrolases (3.1.6)
- C12Y301/06001—Arylsulfatase (3.1.6.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/06—Sulfuric ester hydrolases (3.1.6)
- C12Y301/06008—Cerebroside-sulfatase (3.1.6.8)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Sustainable Development (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361750693P | 2013-01-09 | 2013-01-09 | |
PCT/US2014/010856 WO2014110246A1 (en) | 2013-01-09 | 2014-01-09 | Methods for purification of arylsulfatase a |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1214622A1 true HK1214622A1 (zh) | 2016-07-29 |
Family
ID=50002885
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16102496.7A HK1214622A1 (zh) | 2013-01-09 | 2016-03-04 | 含用於純化芳基硫酸酯酶 的方法 |
HK16104341.0A HK1216429A1 (zh) | 2013-01-09 | 2016-04-15 | 用於純化芳基硫酸酯酶 的方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16104341.0A HK1216429A1 (zh) | 2013-01-09 | 2016-04-15 | 用於純化芳基硫酸酯酶 的方法 |
Country Status (12)
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013009686A2 (en) | 2011-07-08 | 2013-01-17 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase a |
MX2015008875A (es) | 2013-01-09 | 2015-10-22 | Shire Human Genetic Therapies | Metodos para la purificacion de arilsulfatasa a. |
JP6783767B2 (ja) * | 2014-12-22 | 2020-11-11 | アレクシオン ファーマシューティカルズ インコーポレイテッドAlexion Pharmaceuticals, Inc. | 組換えタンパク質を精製する方法 |
CA2995385A1 (en) * | 2015-08-20 | 2017-02-23 | Genentech, Inc. | Purification of fkpa and uses thereof for producing recombinant polypeptides |
CN109069592B (zh) | 2016-03-16 | 2023-03-07 | 菲尼克斯组织修复公司 | 纯化胶原7的方法 |
CN111065735B (zh) * | 2017-08-31 | 2023-07-07 | 株式会社绿十字 | 用于纯化硫酸酯酶蛋白的方法 |
BR112020012637A2 (pt) * | 2017-12-19 | 2020-12-01 | Shire Human Genetic Therapies, Inc | arilsulfatase a purificada e composições da mesma |
KR20200118011A (ko) * | 2018-02-02 | 2020-10-14 | 엔지반트 테라퓨틱스 게엠베하 | 파버병을 치료하는 방법 |
BR112020020854A2 (pt) * | 2018-04-12 | 2021-01-19 | Amgen Inc. | Métodos para produzir composições de proteínas estáveis |
CN112082832B (zh) * | 2019-06-12 | 2022-03-29 | 华南理工大学 | 一种保存城市污水中硫酸酯结合体和葡萄糖苷醛酸结合体的方法 |
CN110632052A (zh) * | 2019-10-25 | 2019-12-31 | 山西师范大学 | 土壤芳基硫酸酯酶活性的荧光光谱检测法 |
CN112759643B (zh) * | 2021-03-17 | 2023-05-30 | 华兰生物工程股份有限公司 | 一种血清白蛋白的脱脂方法 |
CN116693659A (zh) * | 2023-07-11 | 2023-09-05 | 浙江大学 | 一种分离重组人血白蛋白的两步混合模式层析方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4315919A (en) | 1980-10-06 | 1982-02-16 | Edward Shanbrom | Depyrogenation process |
US4314997A (en) | 1980-10-06 | 1982-02-09 | Edward Shanbrom | Purification of plasma protein products |
US4764369A (en) | 1983-07-14 | 1988-08-16 | New York Blood Center Inc. | Undenatured virus-free biologically active protein derivatives |
CA2041280A1 (en) * | 1990-05-10 | 1991-11-11 | Yosuke Sawada | Arylsulfatase |
NO960163D0 (no) | 1996-01-15 | 1996-01-15 | Thomas Berg | Mutasjonsdeteksjon av bovin |
JP2002501032A (ja) | 1998-01-27 | 2002-01-15 | ヘム−バイオテック エイ/エス | 急性間欠性ポルフィリン症(aip)及び他のポルフィリン症の治療方法 |
AU753468B2 (en) | 1998-06-09 | 2002-10-17 | Csl Behring Ag | Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
DK2270044T3 (en) | 1998-06-09 | 2015-01-26 | Csl Behring Ag | Liquid immunoglobulin G (IgG) product |
AUPQ026799A0 (en) | 1999-05-10 | 1999-06-03 | Csl Limited | Method of increasing protein stability by removing immunoglobulin aggregates |
JP2003505057A (ja) | 1999-07-27 | 2003-02-12 | ヘム−バイオテック エイ/エス | rhPBGDの製造及び急性間欠性ポルフィリン症(AIP)及び他のポルフィリン症の患者を処置するための新規な治療方法 |
US6812339B1 (en) | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
AU2002232803A1 (en) | 2000-11-15 | 2002-05-27 | Genzyme Corporation | Expression system for recombinant proteins |
WO2002099092A2 (en) | 2001-06-07 | 2002-12-12 | Hemebiotech A/S | Production of recombinant human lysosomal alpha-mannosidase |
WO2002098455A2 (en) * | 2001-06-07 | 2002-12-12 | Hemebiotech A/S | Production of recombinant human arylsulfatase a |
WO2003002731A1 (en) | 2001-06-29 | 2003-01-09 | Hemebiotech A/S | A PROCESS FOR PURIFICATION OF RECOMBINANT PORPHOBILINOGEN DEAMINASE (rhPBGD) |
US7232670B2 (en) | 2001-09-28 | 2007-06-19 | St. Jude Children's Research Hospital | Targeting proteins to cells expressing mannose receptors via expression in insect cells |
EP2399586A1 (en) | 2002-01-11 | 2011-12-28 | Jefferies, Dr., Wilfred | Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
US7118675B2 (en) | 2002-02-04 | 2006-10-10 | Millipore Corporation | Process for removing protein aggregates and virus from a protein solution |
AU2005209360B2 (en) * | 2004-01-30 | 2009-06-25 | Takeda Pharmaceutical Company Limited | Production and purification of recombinant arylsulfatase A |
PL1740204T3 (pl) | 2004-04-01 | 2018-08-31 | Chiesi Farmaceutici S.P.A. | Lecznicze zastosowanie alfa-mannozydazy |
US20060051347A1 (en) | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
SI2628746T1 (sl) | 2006-04-04 | 2019-04-30 | Chiesi Farmaceutici S.P.A. | Proces za koncentriranje polipeptida |
EP2346900A1 (en) * | 2008-10-29 | 2011-07-27 | Wyeth LLC | Methods for purification of single domain antigen binding molecules |
US8945895B2 (en) * | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
KR102537084B1 (ko) | 2010-06-25 | 2023-05-26 | 샤이어 휴먼 지네틱 테라피즈 인크. | 아릴설파타제 a의 cns 전달을 위한 방법들 및 조성물들 |
LT2588130T (lt) | 2010-06-25 | 2016-12-12 | Shire Human Genetic Therapies, Inc. | Terapinės priemonės pristatymas cns |
GB201012603D0 (en) * | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Protein purification |
MX2015008875A (es) | 2013-01-09 | 2015-10-22 | Shire Human Genetic Therapies | Metodos para la purificacion de arilsulfatasa a. |
-
2014
- 2014-01-09 MX MX2015008875A patent/MX2015008875A/es active IP Right Grant
- 2014-01-09 JP JP2015551870A patent/JP6427502B2/ja active Active
- 2014-01-09 EP EP14701454.2A patent/EP2943568B1/en active Active
- 2014-01-09 CA CA2896979A patent/CA2896979C/en active Active
- 2014-01-09 EA EA201590826A patent/EA030551B1/ru not_active IP Right Cessation
- 2014-01-09 CN CN202011058581.6A patent/CN112126634A/zh active Pending
- 2014-01-09 US US14/759,645 patent/US11407984B2/en active Active
- 2014-01-09 CN CN201480003307.5A patent/CN104903442A/zh active Pending
- 2014-01-09 AU AU2014205441A patent/AU2014205441B2/en active Active
- 2014-01-09 BR BR112015015948-6A patent/BR112015015948B1/pt active IP Right Grant
- 2014-01-09 ES ES14701454T patent/ES2768261T3/es active Active
- 2014-01-09 WO PCT/US2014/010856 patent/WO2014110246A1/en active Application Filing
-
2015
- 2015-07-08 MX MX2020003798A patent/MX2020003798A/es unknown
-
2016
- 2016-03-04 HK HK16102496.7A patent/HK1214622A1/zh unknown
- 2016-04-15 HK HK16104341.0A patent/HK1216429A1/zh unknown
-
2018
- 2018-06-28 JP JP2018122837A patent/JP2018171067A/ja not_active Withdrawn
-
2019
- 2019-09-25 JP JP2019174155A patent/JP2020015750A/ja not_active Withdrawn
-
2020
- 2020-02-14 AU AU2020201079A patent/AU2020201079B2/en active Active
-
2021
- 2021-11-10 JP JP2021183082A patent/JP7407161B2/ja active Active
-
2022
- 2022-07-01 US US17/810,396 patent/US11884945B2/en active Active
- 2022-08-25 AU AU2022221475A patent/AU2022221475A1/en active Pending
-
2023
- 2023-10-04 JP JP2023173170A patent/JP2024001160A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP7407161B2 (ja) | 2023-12-28 |
US20150353904A1 (en) | 2015-12-10 |
BR112015015948B1 (pt) | 2022-05-17 |
HK1216429A1 (zh) | 2016-11-11 |
EA030551B1 (ru) | 2018-08-31 |
BR112015015948A2 (US06229276-20010508-P00077.png) | 2017-08-15 |
AU2020201079A1 (en) | 2020-03-05 |
EA201590826A1 (ru) | 2015-11-30 |
WO2014110246A1 (en) | 2014-07-17 |
MX2020003798A (es) | 2020-08-03 |
EP2943568A1 (en) | 2015-11-18 |
JP2024001160A (ja) | 2024-01-09 |
JP6427502B2 (ja) | 2018-11-21 |
CA2896979C (en) | 2023-05-02 |
AU2022221475A1 (en) | 2022-09-22 |
US11884945B2 (en) | 2024-01-30 |
CN112126634A (zh) | 2020-12-25 |
JP2018171067A (ja) | 2018-11-08 |
AU2014205441B2 (en) | 2019-12-12 |
CA2896979A1 (en) | 2014-07-17 |
AU2014205441A1 (en) | 2015-06-25 |
JP2022023225A (ja) | 2022-02-07 |
JP2020015750A (ja) | 2020-01-30 |
MX2015008875A (es) | 2015-10-22 |
AU2020201079B2 (en) | 2022-05-26 |
CN104903442A (zh) | 2015-09-09 |
JP2016504040A (ja) | 2016-02-12 |
ES2768261T3 (es) | 2020-06-22 |
US20230235303A1 (en) | 2023-07-27 |
US11407984B2 (en) | 2022-08-09 |
EP2943568B1 (en) | 2019-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190197T1 (hr) | Postupci pročišćavanja rna | |
IL240215A0 (en) | Methods for the purification of messenger RNA | |
PL2803401T3 (pl) | Oczyszczanie powietrza | |
HK1216429A1 (zh) | 用於純化芳基硫酸酯酶 的方法 | |
GB201401248D0 (en) | Method of manufacture | |
HK1218014A1 (zh) | 用以間接判定參考間距的方法 | |
SG11201603028SA (en) | Purification of proteins | |
SG11201505198WA (en) | Protein purification methods | |
IL268868B (en) | A new method for protein purification | |
EP2985275A4 (en) | PROCESS FOR PURIFYING BETA-HYDROXY-BETA-METHYLBUTYRIC ACID | |
HK1222339A1 (zh) | 金屬-β-內酰胺酶的抑制劑 | |
IL240763A0 (en) | The halopyrazoles as thrombin inhibitors | |
EP2948557A4 (en) | PURIFICATION OF CADAVERINE | |
ZA201603797B (en) | Novel purification processes | |
GB201305231D0 (en) | Method of Manufacture | |
IL243937A0 (en) | A process for the purification of diaminophenothiazinium compounds | |
GB201305514D0 (en) | Method of water purification | |
HK1216419A1 (zh) | 合成方法 | |
PL3063156T3 (pl) | Sposób oczyszczania lecytyny | |
GB201314581D0 (en) | Purification | |
SG10201701021XA (en) | Method of synthesis | |
GB201311291D0 (en) | Method of manufacture | |
GB201301262D0 (en) | Method of manufacture | |
TWM475821U (en) | Structure of mosquito-catch | |
TWM475524U (en) | Structure of rivet-pulling |